Pliant Therapeutics, Inc. (PLRX) Tops Q3 EPS by 8c

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q3 EPS of ($0.70), $0.08 better than the analyst estimate of ($0.78).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen
• Morgan Stanley upgrades CDW on stronger AI-driven server demand